Notícias e Atividades da ImpediMed

ImpediMed é uma empresa listada sob o símbolo IPD (AU).

Veja o organograma con seus 15 executivos principais

Biografias mais buscadas da ImpediMed

• Parmjot Bains, Managing Director and Chief Executive Officer
• Janelle Delaney, Non-Executive Director
• Christine Emmanuel-Donnelly, Non-Executive Chairman of the Board

Recentes movimentos de executivos em ImpediMed

• Andrew Grant atualmente Executive Director and Vice President, Product Development and Customer Solutions, passará a Non-Executive Director em 19 de nov. de 2024  (Notícia publicada em 21 de outubro de 2024).

Criar um alerta
para seguir os movimentos de executivos da ImpediMed.

ImpediMed possui 1.020 concorrentes concorrentes Philips (Holanda), Medtronic (Irlanda) e Thermo Fisher Scientific (Estados Unidos).

Popular M&A news in Equipamentos Médicos

• Globus Medical has announced the acquisition of Nevro  (publicado em 4 de abril de 2025).
• Amboss acaba de anunciar uma arrecadação de fundos de 259 milhões de dólares. (publicado em 3 de abril de 2025).
• Patricia Industries has announced the acquisition of Nova Biomedical  (publicado em 24 de março de 2025).

Outros contatos sugeridos na indústria do Equipamentos Médicos

• Volker Wetekam - Director da Elekta Instrument
• Andrew Elbardissi - Director da Medical Microinstruments
• Marc Casper - Chairman of the Board, President and Chief Executive Officer da Thermo Fisher Scientific

Saiba mais sobre a indústria do Equipamentos Médicos

Últimos comunicados de imprensa de ImpediMed

• Newsroom | ImpediMed - Part 5
• Newsroom | ImpediMed - Part 4
• Early Detection of Lymphedema and Value of Compression Garments After Breast Cancer Treatments with Dr. Steven Chen | ImpediMed
• New Data Presented at the 2022 San Antonio Breast Cancer Symposium Shows Early Detection using L-Dex and Intervention Improves Lymphedema Progression-Free Survival
• ImpediMed Reaches Milestone of 500,000 Patient Tests Performed with the SOZO Digital Health Platform
• New Data Confirms Early Detection and Intervention of Lymphedema Improves Quality of Life for Breast Cancer Patients Who Avoid Chronic Lymphedema
• Current Data Support Early Detection and Intervention to Reduce Rates of Breast Cancer-Related Lymphedema
• ImpediMed Expands Use of SOZO in Leading Cancer Centers Focused on Reducing the Impact of Lymphedema after Breast Cancer
• ImpediMed Announces U.S. Launch of Lymphedema Prevention Program with GenesisCare a Global Organization Dedicated to Care of Cancer Patients
• ImpediMed Announces Two Posters at Heart Failure Society of America Annual Scientific Meeting That Demonstrate Utility of SOZO® Digital Health Platform for Heart Failure Patients
• View more press releases Close

Redes sociais sobre ImpediMed

• ImpediMed na Wikipedia, Google News e Yahoo Finance
• ImpediMed na LinkedIn, Twitter e YouTube